Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China · Delayed Price · Currency is CNY 5.25
-0.18 (-3.31%)
Jun 8, 2026, 3:04 PM CST
SHE:300639 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -106.43 | -130.94 | -654.88 | 140.47 | 1,726 | 852.16 |
Depreciation & Amortization | 157.17 | 157.17 | 169.77 | 178.43 | 178.89 | 87.3 |
Other Amortization | 20.08 | 20.08 | 28.63 | 13.9 | 14.2 | 16.68 |
Loss (Gain) From Sale of Assets | -0.43 | -0.43 | 0.25 | -7.06 | -4.34 | -2.34 |
Asset Writedown & Restructuring Costs | 15.62 | 15.62 | 24.79 | -1.56 | 291.75 | 6.34 |
Loss (Gain) From Sale of Investments | -3.85 | -3.85 | -9.2 | -13.94 | -21.35 | -20.6 |
Provision & Write-off of Bad Debts | 33.98 | 33.98 | 606.96 | -10.76 | 250.48 | - |
Other Operating Activities | -81.5 | -35.02 | -279.55 | -54.85 | 176.49 | 40.18 |
Change in Accounts Receivable | 337.93 | 337.93 | 161.22 | 873.52 | -1,920 | -648.08 |
Change in Inventory | 8.37 | 8.37 | 18.16 | 52.38 | -63.36 | -51.15 |
Change in Accounts Payable | -60.5 | -60.5 | -113.45 | -802.73 | 698.97 | 289.93 |
Change in Other Net Operating Assets | -1.14 | -1.14 | 11.59 | 11.44 | 61.48 | -17.77 |
Operating Cash Flow | 319.64 | 341.61 | 78.78 | 319.6 | 1,309 | 631.34 |
Operating Cash Flow Growth | 68.46% | 333.63% | -75.35% | -75.59% | 107.37% | 102.81% |
Capital Expenditures | -94.65 | -92.39 | -148.33 | -385.32 | -734.37 | -641.07 |
Sale of Property, Plant & Equipment | 2.35 | 1.64 | 0.4 | 17.74 | 13.72 | 6.34 |
Investment in Securities | -46.6 | -15.9 | 37.58 | 74.73 | 115.89 | 131.39 |
Other Investing Activities | -309.2 | -36.59 | - | 7.64 | - | - |
Investing Cash Flow | -448.08 | -143.25 | -110.35 | -285.21 | -604.75 | -503.35 |
Short-Term Debt Issued | - | - | - | - | - | 248.33 |
Long-Term Debt Issued | - | 46 | 55.32 | 79.86 | 200.79 | - |
Total Debt Issued | 1 | 46 | 55.32 | 79.86 | 200.79 | 248.33 |
Short-Term Debt Repaid | - | - | - | - | - | -172.27 |
Long-Term Debt Repaid | - | -54.02 | -21.01 | -163.82 | -265.91 | -8.25 |
Total Debt Repaid | -54.02 | -54.02 | -21.01 | -163.82 | -265.91 | -180.52 |
Net Debt Issued (Repaid) | -53.02 | -8.02 | 34.3 | -83.97 | -65.12 | 67.81 |
Issuance of Common Stock | - | - | - | - | 10 | 70.25 |
Repurchase of Common Stock | -45.02 | -45.02 | -65.11 | -50 | -50 | -49.97 |
Common Dividends Paid | -3.75 | -3.5 | -44.46 | -160.46 | -114.29 | -76.09 |
Other Financing Activities | -37.9 | -86.58 | -0 | 0.02 | -0 | -3.5 |
Financing Cash Flow | -139.69 | -143.12 | -75.27 | -294.4 | -219.41 | 8.5 |
Foreign Exchange Rate Adjustments | -20.07 | -9.39 | 7.59 | 0.95 | 13.4 | -5.48 |
Net Cash Flow | -288.2 | 45.85 | -99.25 | -259.07 | 498.46 | 131.01 |
Free Cash Flow | 225 | 249.21 | -69.55 | -65.72 | 574.85 | -9.73 |
Free Cash Flow Margin | 34.02% | 37.22% | -8.53% | -5.95% | 10.27% | -0.36% |
Free Cash Flow Per Share | 0.36 | 0.40 | -0.11 | - | 0.87 | -0.01 |
Cash Income Tax Paid | 63.45 | 55.61 | 117.22 | 364.68 | 311.22 | 171.2 |
Levered Free Cash Flow | 550.81 | 299.63 | 300.54 | -75.69 | 74.02 | -231.66 |
Unlevered Free Cash Flow | 552.98 | 301.62 | 301.52 | -72.6 | 79.14 | -227.03 |
Change in Working Capital | 285.01 | 285.01 | 192.02 | 74.97 | -1,303 | -400.44 |